Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy Persistent Systems at Rs. 700/ share in Jan 2020?

News

Stay Updated! In The World Of Investments!
Sensex 60821.62 101.88 (-0.17%)

SMS Pharmaceuticals Latest News

31

Jul, 2021

SMS Pharmaceuticals informs about board meeting

Pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec. 173 of the Companies Act, 2013 SMS Pharmaceuticals has informed that a...

Read More

09

Jul, 2021

SMS Pharmaceuticals informs about certificate

In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, SMS Pharmaceuticals has forwarded a copy of the Certificate dated 7th July, 2021, received from Aarthi Consultants, Hyde...

Read More

25

Jun, 2021

SMS Pharmaceuticals informs about annual secretarial compliance

SMS Pharmaceuticals has submitted the Annual Secretarial Compliance Report issued by CSB Associates, C.Sudhir Babu, Practicing Company Secretary in compliance with Regulation 24A of SEBI (LODR) Regulations, 2015 for...

Read More

24

Jun, 2021

SMS Pharmaceuticals informs about disclosure of related party transactions

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it has enclosed the disclosure of...

Read More

24

Apr, 2021

SMS Pharmaceuticals informs about compliance certificate

Pursuant to the Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it has submitted a Compliance c...

Read More

31

Dec, 2020

SMS Pharmaceuticals informs about closure of trading window

SMS Pharmaceuticals has informed that the Trading Window for dealing in securities of the Company by Directors, Promoters, Designated Employees and Specified Connected Persons of the Company and associated of the Co...

Read More

21

Dec, 2020

SMS Pharmaceuticals informs about disclosure

SMS Pharmaceuticals has informed that the company has received disclosure from the designated employee, Krishna Chaitanya Potluri in pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulatio...

Read More

30

Nov, 2020

SMS Pharmaceuticals informs about disclosure of related party transactions

In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has informed that it has enclosed disclosure of Rel...

Read More

19

Oct, 2020

SMS Pharmaceuticals informs about compliance certificate

Pursuant to the Regulation 40(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has submitted a Compliance certificate issued by C....

Read More

08

Sep, 2020

SMS Pharmaceuticals informs about 32nd annual report

Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SMS Pharmaceuticals has submitted the soft copy of the Annual Report of the Company for the Financial Yea...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback